Physician profile

Thomas Knuth

Surgery · Detroit, MI

NPI 1922023837

$15,477.88

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$78.19

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Avanos Medical $14,584.46 2019-2021
W. L. Gore & Associates, INC. $332.01 2019
Acell, INC. $223.89 2019
Smith+Nephew, INC. $182.61 2019-2023 Grafix Pl
Organogenesis INC. $82.14 2019
Teleflex LLC $31.57 2023 Arrow
My01 INC. $19.15 2023 My01 Continuous Compartmental Pressure Monitor
Tactile Systems Technology INC $11.13 2021
Osiris Therapeutics INC. $10.92 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Knuth

$15,477.88

in general payments reported 2019-2025

Years
2019-2023
Top company
Avanos Medical

https://glasscript.com/doctor/87427/thomas-knuth

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.